UNCY — Unicycive Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
- $34.27m
- $31.53m
- $0.68m
Annual cashflow statement for Unicycive Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.17 | -2.26 | -10 | -18.1 | -30.5 |
| Depreciation | |||||
| Non-Cash Items | 0.684 | 0.971 | 4.35 | 1.22 | 12.3 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.305 | -0.166 | -0.105 | 1.18 | -0.093 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -1.18 | -1.46 | -5.77 | -15.7 | -18.3 |
| Capital Expenditures | — | — | -0.029 | -0.002 | -0.012 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | — | — | -0.029 | -0.002 | -0.012 |
| Financing Cash Flow Items | 0 | -0.117 | 0 | -0.482 | -0.496 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.17 | 1.44 | 22.4 | -0.471 | 27.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.01 | -0.015 | 16.6 | -16.1 | 9.25 |